XML 38 R28.htm IDEA: XBRL DOCUMENT v3.24.3
Share-based compensation (Tables)
9 Months Ended
Sep. 30, 2024
Share-based compensation  
Schedule of share based compensation expense

The Company recorded share-based compensation expense in the following expense categories of its condensed consolidated statements of operations and comprehensive loss (in thousands):

Three Months Ended

Nine Months Ended

September 30, 

September 30, 

    

2024

    

2023

    

2024

    

2023

Research and development expenses

$

4,444

$

3,357

$

13,574

$

11,941

General and administrative expenses

 

4,758

 

4,073

 

14,174

 

12,724

$

9,202

$

7,430

$

27,748

$

24,665

Schedule of share option activity

Number of

Weighted

Shares

Weighted

Average

Aggregate

Underlying

Average

Contractual

Intrinsic

    

Share Options

    

Exercise Price

    

Term

    

Value

(in years)

(in thousands)

Outstanding as of December 31, 2023

 

7,469,527

$

23.13

 

6.83

$

21,920

Granted

 

2,257,808

 

19.21

 

 

Exercised

 

(535,700)

 

13.65

 

 

Forfeited

 

(334,734)

 

28.27

 

 

Outstanding as of September 30, 2024

 

8,856,901

$

22.51

 

7.20

$

43,328

Vested and expected to vest as of September 30, 2024

 

8,856,901

$

22.51

7.20

$

43,328

Options exercisable as of September 30, 2024

 

5,088,727

$

21.33

 

6.01

$

34,254

Schedule of assumptions used to determine the fair value of share options granted

Three Months Ended

Nine Months Ended

 

September 30, 

September 30, 

 

    

2024

    

2023

    

2024

    

2023

 

Risk-free interest rate

 

3.9

%  

4.1

%  

4.0

%  

3.9

%

Expected volatility

 

74.1

%  

83.3

%  

77.3

%  

83.5

%

Expected dividend yield

 

 

 

 

Expected term (in years)

 

6.1

 

6.1

 

6.1

 

6.1

Summarizes activity for RSUs under the 2020 Plan

Number of Shares

Weighted-Average

Underlying RSUs

Grant Date Fair Value

Unvested at December 31, 2023

326,848

$

37.40

Granted

615,496

18.25

Vested and settled

(114,799)

37.31

Vested and deferred(1)

(31,500)

18.07

Forfeited

(15,119)

18.89

Unvested outstanding at September 30, 2024

780,926

23.46

Vested but subject to deferred settlement at September 30, 2024(1)

31,500

18.07

Outstanding at September 30, 2024

812,426

$

23.25

(1)The Company granted certain RSUs to the Company’s non-employee directors which provided for deferred settlement of the RSUs to a specified date following the first to occur of (i) the date of the director’s separation from service, (ii) the date of the director’s disability, (iii) the date of the director’s death, or (iv) the date of a change in control event.